These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410 [TBL] [Abstract][Full Text] [Related]
3. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529 [TBL] [Abstract][Full Text] [Related]
4. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. Ball JM; Rushlow KE; Issel CJ; Montelaro RC J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556 [TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160 [TBL] [Abstract][Full Text] [Related]
6. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603 [TBL] [Abstract][Full Text] [Related]
10. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies. Tschetter JR; Byrne KM; Perryman LE; McGuire TC Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283 [TBL] [Abstract][Full Text] [Related]
11. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus. Grund CH; Lechman ER; Issel CJ; Montelaro RC; Rushlow KE J Gen Virol; 1994 Mar; 75 ( Pt 3)():657-62. PubMed ID: 7510329 [TBL] [Abstract][Full Text] [Related]
12. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. Montelaro RC; Parekh B; Orrego A; Issel CJ J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055 [TBL] [Abstract][Full Text] [Related]
13. Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression. Bailat AS; Soutullo AR; García MI; Veaute CM; Garcia L; Racca AL; Malan Borel IS Arch Virol; 2008; 153(10):1909-15. PubMed ID: 18825485 [TBL] [Abstract][Full Text] [Related]
14. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses. Jin S; Issel CJ; Montelaro RC Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516 [TBL] [Abstract][Full Text] [Related]
15. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Howe L; Leroux C; Issel CJ; Montelaro RC J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301 [TBL] [Abstract][Full Text] [Related]
16. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26. Hussain KA; Issel CJ; Rwambo PM; Arnizaut AB; Ball JM; Schnorr KL; Montelaro RC J Gen Virol; 1988 Jul; 69 ( Pt 7)():1719-24. PubMed ID: 2839604 [TBL] [Abstract][Full Text] [Related]
17. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides. Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689 [TBL] [Abstract][Full Text] [Related]
18. Validation of an immunoblot assay employing an objective reading system and used as a confirmatory test in equine infectious anaemia surveillance programs. Scicluna MT; Autorino GL; Cook SJ; Issel CJ; Cook RF; Nardini R J Virol Methods; 2019 Apr; 266():77-88. PubMed ID: 30684508 [TBL] [Abstract][Full Text] [Related]
19. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90]. Dai CB; Xiao Y; Lu H; Shen RX; Shao YM Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025 [TBL] [Abstract][Full Text] [Related]
20. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Fraser DG; Oaks JL; Brown WC; McGuire TC Immunology; 2002 Mar; 105(3):295-305. PubMed ID: 11918691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]